Stents Drug Eluting

This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.

News

April 18, 2008 - Boston Scientific Corpo. has received approval for the sale of its TAXUS Liberte paclitaxel-eluting ...

Home April 17, 2008
Home
News

April 8, 2008 - The government on Monday said it would raise payments next year to insurers that provide healthcare ...

Home April 07, 2008
Home
News

April 8, 2008 - The first-in-man study funded by MIV Therapeutics Inc. (MIV) showed that MIV's VESTAsync stents ...

Home April 07, 2008
Home
News

April 8, 2008 - A study using Itamar Medical's Endo-PAT2000, an FDA-cleared device used to assess endothelial function ...

Home April 07, 2008
Home
News

April 8, 2008 - People who are taking three or more drugs and still have high blood pressure have a condition known as ...

Home April 07, 2008
Home
News

April 3, 2008 - Patients treated with the TAXUS Stent had significant reductions in one-year revascularization rates in ...

Home April 02, 2008
Home
News

April 1, 2008 - Despite the known increased rates of mortality and restenosis for diabetics versus non-diabetics in ...

Home April 01, 2008
Home
News

April 1, 2008 – Boston Scientific welcomed results from Abbott’s prospective, randomized, single blind, two-year SPIRIT ...

Home March 31, 2008
Home
News

April 1, 2008 – Boston Scientific announced results from an analysis two-year data from more than 7,000 patients in the ...

Home March 31, 2008
Home
News

April 1, 2008 — A large community-based registry of patients treated with drug eluting stents is providing important ...

Home March 31, 2008
Home
News

April 1, 2008 — Early results of the SPIRIT II study showed that the XIENCE V sstent was superior to the Taxus stent in ...

Home March 31, 2008
Home
News

April 1, 2008 — An angioplasty balloon coated with a drug that reduces renarrowing of the coronary arteries appears to ...

Home March 31, 2008
Home
News

March 31, 2008 - New evidence from a large randomized study is answering important questions about the best approach to ...

Home March 30, 2008
Home
News

March 31, 2008 - Although drug-eluting stents have become widely used for the treatment of stable coronary artery ...

Home March 30, 2008
Home
News

March 30, 2008 - One-year data from the ENDEAVOR IV trial showing strong clinical efficacy for Medtronic's Endeavor drug ...

Home March 29, 2008
Home
Subscribe Now